The bleomycin animal model: A useful tool to investigate treatment options for idiopathic pulmonary fibrosis?
Antje Moeller, Kjetil Ask, David Warburton et al. · The International Journal of Biochemistry & Cell Biology · 2007
Cited by 1,000 works. doi:10.1016/j.biocel.2007.08.011
Authors
References
- American Thoracic Society/European Respiratory Society International Multidisciplinary Consensus Classification of the Idiopathic Interstitial Pneumonias
- Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment: International Consensus Statement
- A Placebo-Controlled Trial of Interferon Gamma-1b in Patients with Idiopathic Pulmonary Fibrosis
- Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis
- The Prognostic Significance of the Histologic Pattern of Interstitial Pneumonia in Patients Presenting with the Clinical Entity of Cryptogenic Fibrosing Alveolitis
- Tumor necrosis factor/cachectin plays a key role in bleomycin-induced pneumopathy and fibrosis.
- A Histologic Pattern of Nonspecific Interstitial Pneumonia Is Associated with a Better Prognosis Than Usual Interstitial Pneumonia in Patients with Cryptogenic Fibrosing Alveolitis
- High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis
- Simple method of estimating severity of pulmonary fibrosis on a numerical scale.
- "Compendium of pharmaceuticals and specialties".